Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VYCOR MEDICAL INC (VYCO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | 11.0% | 10.3% | 9.9% | 9.7% | 9.7% | 10.5% |
| Gross profit | | | 89.0% | 89.7% | 90.1% | 90.3% | 90.3% | 89.5% |
| Selling, general and administrative | | | 114.4% | 114.4% | 104.5% | | 117.0% | 126.3% |
| Research and development | | | | | | 1.1% | 0.6% | 0.5% |
| General and administrative | | | | | | 27.5% | | |
| EBITDA | | | -25.8% | -25.1% | -15.0% | -26.4% | -27.2% | -37.3% |
| Depreciation | | | 5.0% | 4.9% | 4.4% | 4.1% | 3.7% | 3.5% |
| EBITA | | | -30.8% | -30.0% | -19.4% | -30.5% | -30.8% | -40.8% |
| Amortization of intangibles | | | | | | 0.8% | 0.8% | 0.9% |
| EBIT | | | -31.0% | -30.4% | -20.0% | -31.3% | -31.7% | -41.7% |
| Pre-tax income | | | -38.3% | -28.1% | -17.8% | -29.3% | -29.6% | -47.7% |
| Income taxes | | | 0.4% | 0.6% | 1.1% | 2.0% | 2.2% | 0.4% |
| Net income | | | -65.3% | -54.6% | -41.9% | -54.6% | -54.8% | -72.0% |
|